SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update
Cephalalgia · 2024
DOI: 10.1177/03331024241232256 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cephalalgia, 2024. Verfasst von Mi-Kyoung Kang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea. Hauptthemen laut MEDLINE: SUNCT Syndrome, Neuralgia, Trigeminal Autonomic Cephalalgias. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Short-lasting unilateral neuralgiform headache attacks (SUNHA) have the features of both short-lasting unilateral neuralgiform pain, such as trigeminal neuralgia or stabbing headache, and associated trigeminal autonomic symptoms, such as paroxysmal hemicrania or cluster headache. Recognizing and adequately treating SUNHA is essential but current treatment methods are ineffective in treating SUNHA.
Methods
We reviewed the changes in the concept of short-lasting unilateral neuralgiform headache attacks and provide a narrative review of the current medical and surgical treatment options, from the first choice of treatment for patients to treatments for selective intractable cases.
Results
Unlike the initial impression of an intractable primary headache disorder affecting older men, SUNHA affects both sexes throughout their lifespan. One striking feature of SUNHA is that the attacks are triggered by cutaneous or intraoral stimulation. The efficacy of conventional treatments is disappointing and challenging, and preventive therapy is the mainstay of treatment because of highly frequent attacks of a very brief duration. Amongst them, lamotrigine is effective in approximately two-third of the patients with SUNHA, and intravenous lidocaine is essential for the management of acute exacerbation of intractable pain. Topiramate, oxcarbazepine and gabapentin are considered good secondary options for SUNHA, and botulinum toxin can be used in selective cases. Neurovascular compression is commonly observed in SUNHA, and surgical approaches, such as neurovascular compression, have been reported to be effective for intractable cases.
Conclusions
Recent advances in the understanding of SUNHA have improved the recognition and treatment approaches for this unique condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, South Korea.
ORCID-Profile: Mi-Kyoung Kang, Soo-Jin Cho
Zitieren
APA
Kang, M. K., & Cho, S. J. (2024). SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update. Cephalalgia. https://doi.org/10.1177/03331024241232256
Vancouver
Kang MK, Cho SJ. SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update. Cephalalgia. 2024. doi:10.1177/03331024241232256
BibTeX
@article{Kang2024,
author = {Kang, Mi-Kyoung and Cho, Soo-Jin},
title = {SUNCT, SUNA and short-lasting unilateral neuralgiform headache attacks: Debates and an update},
journal = {Cephalalgia},
year = {2024},
doi = {10.1177/03331024241232256}
}
EUVIMED